# Volume IV Acceptance Record

**Result:** PASS — Volume IV acceptance criteria are met; this record is followed by the local freeze commit.
**Scope:** Phase 11 real-time operations, resilience and federation; Phase 12 aggregate Analytics and downstream DHIS2 integration. Volume V was not started.

## Frozen phase baselines

- Volume IV design freeze: `25b4c63`.
- Phase 11 authorization baseline: `b9d33737077e6f40a334608824246214d80654fc`.
- Phase 11 implementation freeze: `b19a8ddf98465c5d9ce0e0ebf525354c955f4b15`.
- Phase 11 verification follow-up: `c72c9fb9dce4283d40a210c66279363fc3d7bfc1`.
- Phase 12 implementation freeze: `2835c3455c5a0e0fe4258da64df355e2f8e7da45`.

Phase 11's accepted follow-up is part of the baseline. Its local acceptance record documents outbox-backed notification projection, bounded SSE, revocation, local peer trust, owner-local federation, remote Capacity freshness, reservation recovery, and no shared business database. Phase 12 consumes bounded Referral and Transfer reporting contracts, computes versioned aggregates, gates all outbound disclosure through shared stable lineages, and uses Phase 9 for DHIS2 and aggregate-peer exchange.

## Integrated happy-path tracer

The integrated evidence is a compositional local tracer across the full clean verification suite rather than one test method holding a single synthetic journey across two application processes:

1. Phase 11 PostgreSQL-backed federation and owner tests exercise local origin/receiving coordination, separately owned receiving assessment and Capacity reservation, stable operation receipts, duplicate recovery, and the lost-response path. The Phase 11 notification tests exercise scoped SSE hints, authorized owner refresh, reconnect, and projection recovery.
2. `ReferralReportingSnapshotsIT` and `TransferReportingSnapshotPostgresIT` prove that only owner-produced aggregate measures and explicit attribution reach Analytics.
3. `AnalyticsAggregateComputationPostgresIT` and `AnalyticsSnapshotRevisionPostgresIT` exercise versioned periods, completeness, aggregation, and immutable revisions.
4. `Dhis2AggregateExportPostgresIT` sends a single-value aggregate through Phase 9 to a controlled local TLS mock. `FederatedAggregateFederationPostgresIT` tests the named local peer contract and proves that peer publication and DHIS2 export serialize through the same PostgreSQL disclosure lineage.
5. A fresh isolated Compose runtime starts the built application, applies all migrations, and returns `UP` on the localhost health endpoint.

This composition preserves the source-of-truth boundaries: notification receipt is followed by an authorized owner query; federation requests are handled by owner contracts; Analytics consumes only bounded owner snapshots; and DHIS2 acknowledgement is recorded as delivery evidence, not operational or analytical truth. The integration evidence does not claim one full cross-deployment care journey was then submitted as a DHIS2 value in the same test process.

## Integrated failure and recovery tracer

Local tests cover the failure sequence by failure domain:

- Phase 11 tests exercise interrupted notification delivery, durable projection recovery, disconnected/reconnected clients, peer outage/partition, stable operation replay, changed-fingerprint conflict, unknown outcome after a remote commit, and peer revocation before retry.
- Phase 12 computation and revision tests exercise recoverable reporting work and late facts without gating owner transactions.
- DHIS2 tests exercise local mock unavailability/response loss after synthetic commit, persistent `OUTCOME_UNKNOWN`, retained target-tuple and disclosure reservations, no blind resend, and authorized reconciliation before a newer revision can proceed.
- Compose smoke confirms the application and PostgreSQL schema recover and become ready together after a fresh local initialization.

These tests use synthetic identifiers, local PostgreSQL/Testcontainers and controlled local peer/TLS fixtures only. No external healthcare, DHIS2, government, cloud, or federation endpoint was used.

## Privacy and ownership

Phase 11 keeps notification payloads bounded to owner/resource/version hints and federation messages to namespaced operational references. Phase 12 Analytics persists bounded aggregate inputs and results only. The Phase 12 privacy marker is asserted absent from federated message serialization, and owner/report/export contracts exclude patient and clinical models by type and architecture rule. The shared disclosure gate considers related outputs, prior releases and unknown outcomes under stable lineages and serializes concurrent reservations in real PostgreSQL.

An exhaustive scan of every runtime logging, metrics, tracing, and Problem Details backend was not performed as one unified volume-level operation. The acceptance evidence instead combines focused privacy and architecture tests with the bounded contracts and safe-observability rules. This limitation is explicit; no real patient data or production credentials were used.

## Persistence and dependency audit

The isolated Compose database reported these application schemas: `analytics`, `audit`, `capacity`, `directory`, `identity_access`, `matching`, `platform_eventing`, `platform_exchange`, `platform_federation`, `platform_notification`, `referral`, `transfer`, and `transport`, with PostgreSQL's `public` schema. Flyway applied 90 migrations through V90. The schema audit found zero cross-schema foreign keys. No patient warehouse, tracker, clinical warehouse, DHIS2 mirror-as-authority, or Volume V schema/package was added.

`pom.xml` and `compose.yaml` have no Phase 12 changes from the starting baseline. No DHIS2/Tracker SDK, broker, Redis, Spark, Flink, Hadoop, OLAP/database warehouse, cloud analytics SDK, or AI/LLM dependency was introduced. The existing CI workflow runs `clean verify`; no guardrail replacement was needed.

## Verification and regression

Canonical command: `\.\mvnw.cmd -B -ntp clean verify`

Result: **BUILD SUCCESS** on Eclipse Temurin Java 25.0.4.1, Apache Maven 3.10.0 and Spring Boot 4.1.1. Surefire: 440 tests, 0 failures, 0 errors, 0 skipped. Failsafe: 396 tests, 0 failures, 0 errors, 0 skipped. Flyway: 90 migrations. The complete suites include regression coverage for Volumes I–III and Phase 11, together with Phase 12 local PostgreSQL, local exchange, privacy, and architecture tests.

Local runtime smoke used an isolated Compose project, synthetic settings, localhost-only ports and disposable database/keycloak containers. It returned health `UP`, confirmed schema inventory/migration state and zero cross-schema foreign keys; the isolated project and volumes were removed after the query. The Phase 12 build made no permanent Compose changes.

## Independent final review

Independent Phase 12 standards and specification review, followed by independent combined Volume IV standards and specification review, reported **0 unresolved BLOCKER and 0 unresolved MAJOR**. Remaining notes:

- **MINOR:** automated dimensional coarsening is not implemented; unsafe/uncertain releases fail closed or require the configured review path.
- **MINOR:** several Analytics service paths repeat authentication-evidence conversion; no ownership or behavior defect was identified.
- **DOCUMENTATION:** contributor schema/status guidance was stale; the Phase 12 retro updates corrected it, and the architecture index now links both phase acceptance records and Volume IV closeout.

No mandatory pre-freeze question remains. Deployment configuration remains responsible for the indicator catalogue, reporting calendar/timezone, privacy policy, DHIS2 mappings/authentication, target write-authority arrangement, and retention/correction windows. Advanced public-health analytics and any later-volume work remain future scope.

## Safety and scope

- No public/demo/shared DHIS2, government/public-health, public healthcare, external peer, EMS, or external identity provider was used for functional testing.
- No external mutation, metadata creation, OAuth registration, publication, deployment, or remote Git write occurred.
- No real patient/public-health data or production credentials were used.
- No patient-level Tracker/Event export, Phase 12 operational feedback path, or Volume V implementation was added.

**Acceptance gate:** PASS. Phase 11 and Phase 12 are frozen; Volume IV is ready for its local freeze commit.
